Kestra Advisory Services’s Transmedics TMDX Stock Holding History

Kestra Advisory Services’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$311K	Sell	4,688 -584	-11%	-$49.4K	﹤0.01%	2733
2026 Q1	$524K	Sell	5,272 -397	-7%	-$51.8K	﹤0.01%	2182
2025 Q4	$690K	Sell	5,669 -936	-14%	-$117K	﹤0.01%	1923
2025 Q3	$741K	Buy	6,605 +624	+10%	+$73K	﹤0.01%	1798
2025 Q2	$802K	Buy	5,981 +1,430	+31%	+$157K	﹤0.01%	1637
2025 Q1	$306K	Sell	4,551 -548	-11%	-$37.7K	﹤0.01%	2158
2024 Q4	$318K	Buy	5,099 +2,479	+95%	+$231K	﹤0.01%	2179
2024 Q3	$411K	Sell	2,620 -1,294	-33%	-$199K	﹤0.01%	1889
2024 Q2	$590K	Buy	+3,914	New	+$469K	﹤0.01%	1669

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Kestra Advisory Services's TMDX Position: Q2 2026 in Review

Kestra Advisory Services reduced its Transmedics (TMDX) stake by 11% in Q2 2026, selling an estimated $49.4K and leaving 4,688 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2733.

Kestra Advisory Services first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $802K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Kestra Advisory Services held 4,688 shares of Transmedics worth $311K as of Q2 2026.
Kestra Advisory Services sold 584 Transmedics shares in Q2 2026, an estimated $49.4K.
Transmedics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2733 holding.
Kestra Advisory Services first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
Kestra Advisory Services's Transmedics position peaked at $802K in Q2 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.